164 related articles for article (PubMed ID: 26464616)
1. Roles of Foxp3 in the occurrence and development of cervical cancer.
Luo Q; Zhang S; Wei H; Pang X; Zhang H
Int J Clin Exp Pathol; 2015; 8(8):8717-30. PubMed ID: 26464616
[TBL] [Abstract][Full Text] [Related]
2. Up-regulation of Foxp3 participates in progression of cervical cancer.
Zeng C; Yao Y; Jie W; Zhang M; Hu X; Zhao Y; Wang S; Yin J; Song Y
Cancer Immunol Immunother; 2013 Mar; 62(3):481-7. PubMed ID: 22986453
[TBL] [Abstract][Full Text] [Related]
3. [Study of p16(INK4A) expression and DNA ploidy in HPV-negative cervical cancers and precursors].
Lin ZH; Liu MZ; Zhao YW; Wu QY; Liu SP; Kim I
Zhonghua Bing Li Xue Za Zhi; 2006 Jul; 35(7):412-6. PubMed ID: 17069677
[TBL] [Abstract][Full Text] [Related]
4. Oncogene ATAD2 promotes cell proliferation, invasion and migration in cervical cancer.
Zheng L; Li T; Zhang Y; Guo Y; Yao J; Dou L; Guo K
Oncol Rep; 2015 May; 33(5):2337-44. PubMed ID: 25813398
[TBL] [Abstract][Full Text] [Related]
5. The hypermethylation and protein expression of p16 INK4A and DNA repair gene O6-methylguanine-DNA methyltransferase in various uterine cervical lesions.
Lin Z; Gao M; Zhang X; Kim YS; Lee ES; Kim HK; Kim I
J Cancer Res Clin Oncol; 2005 Jun; 131(6):364-70. PubMed ID: 15785933
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of p16INK4a and pRb expression in cervical squamous and glandular neoplasia.
Tringler B; Gup CJ; Singh M; Groshong S; Shroyer AL; Heinz DE; Shroyer KR
Hum Pathol; 2004 Jun; 35(6):689-96. PubMed ID: 15188135
[TBL] [Abstract][Full Text] [Related]
7. Expression of transcription factor FOXC2 in cervical cancer and effects of silencing on cervical cancer cell proliferation.
Zheng CH; Quan Y; Li YY; Deng WG; Shao WJ; Fu Y
Asian Pac J Cancer Prev; 2014; 15(4):1589-95. PubMed ID: 24641373
[TBL] [Abstract][Full Text] [Related]
8. The expression of Foxp3 and TLR4 in cervical cancer: association with immune escape and clinical pathology.
Zhang H; Zhang S
Arch Gynecol Obstet; 2017 Mar; 295(3):705-712. PubMed ID: 28013346
[TBL] [Abstract][Full Text] [Related]
9. High-mobility group box 1 is overexpressed in cervical carcinoma and promotes cell invasion and migration in vitro.
Pang X; Zhang Y; Zhang S
Oncol Rep; 2017 Feb; 37(2):831-840. PubMed ID: 28000879
[TBL] [Abstract][Full Text] [Related]
10. Liquid-based cytology--new possibilities in the diagnosis of cervical lesions.
Juric D; Mahovlić V; Rajhvajn S; Ovanin-Rakić A; Skopljanac-Macina L; Barisić A; Projić IS; Babić D; Susa M; Corusić A; Oresković S
Coll Antropol; 2010 Mar; 34(1):19-24. PubMed ID: 20432728
[TBL] [Abstract][Full Text] [Related]
11. Expression and effects of high-mobility group box 1 in cervical cancer.
Pang X; Zhang Y; Wei H; Zhang J; Luo Q; Huang C; Zhang S
Int J Mol Sci; 2014 May; 15(5):8699-712. PubMed ID: 24837834
[TBL] [Abstract][Full Text] [Related]
12. p16INK4A as a marker for cervical dyskaryosis: CIN and cGIN in cervical biopsies and ThinPrep smears.
Murphy N; Ring M; Killalea AG; Uhlmann V; O'Donovan M; Mulcahy F; Turner M; McGuinness E; Griffin M; Martin C; Sheils O; O'Leary JJ
J Clin Pathol; 2003 Jan; 56(1):56-63. PubMed ID: 12499437
[TBL] [Abstract][Full Text] [Related]
13. Up-regulation of expression and lack of 5' CpG island hypermethylation of p16 INK4a in HPV-positive cervical carcinomas.
Ivanova TA; Golovina DA; Zavalishina LE; Volgareva GM; Katargin AN; Andreeva YY; Frank GA; Kisseljov FL; Kisseljova NP
BMC Cancer; 2007 Mar; 7():47. PubMed ID: 17359536
[TBL] [Abstract][Full Text] [Related]
14. Sex-determining region Y-related high mobility group box (SOX)-2 is overexpressed in cervical squamous cell carcinoma and contributes cervical cancer cell migration and invasion in vitro.
Chang X; Zhang J; Huang C; Pang X; Luo Q; Zhang H; Zhang S
Tumour Biol; 2015 Sep; 36(10):7725-33. PubMed ID: 25935536
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical study of p16 INK4A and survivin expressions in cervical squamous neoplasm.
Tan GC; Norlatiffah S; Sharifah NA; Razmin G; Shiran MS; Hatta AZ; Paul-Ng HO
Indian J Pathol Microbiol; 2010; 53(1):1-6. PubMed ID: 20090212
[TBL] [Abstract][Full Text] [Related]
16. [Expression and clinical significance of Dyrk1b in the specimens and cells of cervical lesions].
Lin J; Zhang P; Pang L; Chen J; Sun W; Qi W; Lyu Y; Guan H; Gao J
Zhonghua Fu Chan Ke Za Zhi; 2016 Jan; 51(1):40-5. PubMed ID: 26899006
[TBL] [Abstract][Full Text] [Related]
17. p16INK4A, CDC6, and MCM5: predictive biomarkers in cervical preinvasive neoplasia and cervical cancer.
Murphy N; Ring M; Heffron CC; King B; Killalea AG; Hughes C; Martin CM; McGuinness E; Sheils O; O'Leary JJ
J Clin Pathol; 2005 May; 58(5):525-34. PubMed ID: 15858126
[TBL] [Abstract][Full Text] [Related]
18. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients.
Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F
Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190
[TBL] [Abstract][Full Text] [Related]
19. Aberrant Expressions of Immune Factors Facilitate the Disequilibrium of Immune Status in Cervical Cancer.
Zhao MY; Zhao J; Yang T; Wang L; Pei ML; Tian SJ; Yu Y; Yang XF
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2016 Oct; 38(5):522-527. PubMed ID: 27825407
[TBL] [Abstract][Full Text] [Related]
20. Expressions of programmed death (PD)-1 and PD-1 ligand (PD-L1) in cervical intraepithelial neoplasia and cervical squamous cell carcinomas are of prognostic value and associated with human papillomavirus status.
Yang W; Lu YP; Yang YZ; Kang JR; Jin YD; Wang HW
J Obstet Gynaecol Res; 2017 Oct; 43(10):1602-1612. PubMed ID: 28833798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
